Results 271 to 280 of about 342,150 (384)

Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.

Gastroenterology, 2016
Yuchen Xia, Daniela Stadler, J. Lucifora, F. Reisinger, D. Webb, M. Hösel, T. Michler, K. Wisskirchen, Xiaoming Cheng, Ke Zhang, Wen-Min Chou, J. Wettengel, A. Malo, F. Bohne, D. Hoffmann, F. Eyer, R. Thimme, C. Falk, W. Thasler, M. Heikenwalder, U. Protzer   +20 more
semanticscholar   +1 more source

Employment Status of Patients With Liver Disease: A Nationwide Questionnaire Survey in Japan

Hepatology Research, EarlyView.
In our nationwide survey, analyzing over 2000 patients, those with viral hepatitis were less likely to disclose their condition, and overall awareness of support programs remained limited. These findings highlight the need to promote support for balancing treatment and work more actively, particularly in small‐ and medium‐sized workplaces.
Yoshio Tokumoto, Yoichi Hiasa, Yoshihito Uchida, Takashi Oono, Atsushi Yukimoto, Takao Watanabe, Ryo Sasaki, Sachiko Tatsuki, Hironori Tanaka, Takako Inoue, Mika Horino, Akira Hirose, Tadashi Ikegami, Jun Inoue, Hiroshi Isoda, Hirokazu Takahashi, Yoshihisa Arao, Isao Hidaka, Hiroki Tojima, Satoru Kakizaki, Tetsuro Shimakami, Masayuki Tatemichi, Tatehiro Kagawa, Koji Ogawa, Masatsugu Ohara, Ritsuzo Kozuka, Masaru Enomoto, Mizuki Endo, Yuichiro Eguchi, Kenji Nagata, Masaaki Korenaga   +30 more
wiley   +1 more source

Knowledge and Prevalence of Hepatitis B and C Viral Infections Among Beauticians: A Cross-Sectional Study in the Ejisu-Juaben Municipality of the Ashanti Region, Ghana. [PDF]

Health Sci Rep
Awortwe KY, Gawey D, Abbiw GO, Acheampong I, Wireko S, Domfeh SA.   +5 more
europepmc   +1 more source

I-5 HBV genome oncogenic mutations in Chinese HCC patients related to chronic HBV infection

, 2008
Fang-Ting Lu, Suwen Jiang, X.M. Chen, Hui Zhuang   +3 more
openalex   +1 more source

Efficacy and Safety of Hypofractionated Radiation Therapy Combined With Immunotherapy for Hepatocellular Carcinoma With Vp4 Portal Vein Tumor Thrombosis

Hepatology Research, EarlyView.
ABSTRACT Background Hepatocellular carcinoma (HCC) with Vp4 portal vein tumor thrombosis (PVTT) has an extremely poor prognosis, and evidence for effective systemic therapy is limited. Preclinical studies suggest that hypofractionated radiation therapy (HFRT) may enhance immune checkpoint inhibitor (ICI) efficacy through immunogenic cell death and ...
Masahiko Tameda, Hideaki Tanaka, Yutaka Toyomasu, Mizuki Kawachi, Hirono Owa, Mone Tsukimoto, Yasuyuki Tamai, Naoto Fujiwara, Ryuta Shigefuku, Suguru Ogura, Yoshihito Nomoto, Hayato Nakagawa   +11 more
wiley   +1 more source

The Prevalence and Risk Factors of Hepatitis B, Hepatitis C, and Hepatitis D Coinfection in Iran's General Population Over the Past 25 Years: A Systematic Review and Meta-Analysis. [PDF]

J Epidemiol Glob Health
Naderi M, Kordkatuli K, Makokha GN, Moradi A, Mehravar F, Hijikata M, Chayama K.   +6 more
europepmc   +1 more source

Population‐Based Molecular Surveillance of Hepatitis B Virus Genotypes in the Goto Islands, Japan: A Three Decade Study (1977–2008) of 916 Carriers

Hepatology Research, EarlyView.
ABSTRACT Aims Understanding the molecular characteristics and genotype distribution of hepatitis B virus (HBV) is essential to elucidate intra and inter community transmission routes, identify cluster cases, and assess clinical implications based on genotype‐specific virulence.
Ko Ko, Golda Akuffo Ataa, Kazumi Yamasaki, Kazuhiro Hirase, Takahiro Yasaka, Satoshi Shirahama, Tomoyuki Akita, Aya Sugiyama, Shingo Fukuma, Kazuaki Takahashi, Junko Tanaka   +10 more
wiley   +1 more source

mRNA vaccines for HBV: Mechanisms, preclinical advances, and therapeutic clinical progress. [PDF]

Mol Ther Nucleic Acids
Pechnikova NA, Zafeiriou-Chatziefraimidou M, Poimenidou M, Patsidou C, Iliadis I, Ostankova YV, Yaremenko AV.   +6 more
europepmc   +1 more source

Clinical Outcomes of Reduced‐Dose Cabozantinib as Third‐ or Later‐Line Therapy After Immune Checkpoint Inhibitors in Advanced Hepatocellular Carcinoma: A Real‐World Study

Hepatology Research, EarlyView.
In this real‐world post‐ICI setting, cabozantinib demonstrated meaningful clinical activity even at reduced doses, with disease control achieved in nearly half of patients. Importantly, preserved liver function (Child–Pugh class A) was the only determinant of both disease control and overall survival.
Teiji Kuzuya, Hisanori Muto, Yoshihiko Tachi, Mizuki Ariga, Sayaka Morisaki, Gakushi Komura, Takuji Nakano, Hiroyuki Tanaka, Kazunori Nakaoka, Eizaburo Ohno, Kohei Funasaka, Mitsuo Nagasaka, Ryoji Miyahara, Yoshiki Hirooka   +13 more
wiley   +1 more source

Optimization of lipid nanoparticles loaded with ribonucleoprotein-oligonucleotide complexes for in vivo delivery of a CRISPR/Cas9 system targeting hepatitis B virus. [PDF]

Virus Res
Akhter R, Kitab B, Kayesh MEH, Shimizu R, Onuma H, Yamamoto N, Ogawa S, Sugiyama M, Tanaka Y, Sato Y, Kohara M, Tsukiyama-Kohara K.   +11 more
europepmc   +1 more source